Those famous red pills-Deliberations and hesitations. Ethics of placebo use in therapeutic and research settings

European Neuropsychopharmacology

Volumn 22, Issue 11, 2012, Pages 775-781

  Touwen, D P ^a   Engberts, D P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Doctor patient relationship; Ethics; Informed consent; Placebo; Psychiatry; Research

Indexed keywords

PLACEBO;

ALTERNATIVE MEDICINE; ARTICLE; DOCTOR PATIENT RELATION; EQUIPOISE; EVIDENCE BASED MEDICINE; HEALTH CARE; HUMAN; INFORMED CONSENT; MEDICAL CARE; MEDICAL ETHICS; MEDICAL RESEARCH; PHYSICIAN; PLACEBO EFFECT; PRIORITY JOURNAL; PSYCHIATRY; TREATMENT OUTCOME;

CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; INFORMED CONSENT; MENTAL DISORDERS; PHARMACOLOGY, CLINICAL; PHYSICIAN-PATIENT RELATIONS; PLACEBOS; PSYCHOPHARMACOLOGY; TRUST; WITHHOLDING TREATMENT;

EID: 84867552663     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2012.03.005     Document Type: Article

References (39)

1. Ackerman T.F. Therapeutic beneficence and placebo controls. Am. J. Bioethics 2002, 2(2):21-22.
2. American Medical Association, 2007. Code of Medical Ethics. Opinion 8.083 Placebo Use in Medical Practice.
3. Beauchamp T.L., Childress J.F. Principles of biomedical ethics 2008, Oxford University Press, New York/Oxford. sixth ed.
4. Barnhill A. What it takes to defend deceptive placebo use. Kennedy Inst. Ethics J. 2011, 21(3):219-250.
5. Bensing J.M., Verheul W. The silent healer: the role of communication in placebo effects. Patient Educ. Counseling 2010, 80:293-299.
6. Brody B.A. Ethical issues in clinical trials in developing countries. Stat. Med. 2002, 21:2853-2888.
7. Brown W.A. Understanding and using the placebo effect. Psychiatr. Times 2006, 23:11.
8. Clifford V. The placebo mystique: implications for clinical trial methodology. J. Paediatr. Child Health 2011, 47:361-366.
9. Coleman, C.H., et al., 2005. The Ethics and Regulation of Research with Human Subjects. LexisNexis, Newark.
10. De Craen, A.J.M., 1998. Placebos and Placebo Effects in Clinical Trials. University of Amsterdam, Amsterdam.
11. Emanuel E.J., Miller F.G. The ethics of placebo-controlled trials-a middle ground. New Engl. J. Med. 2001, 345(12):915-919.
12. Faden R., Beauchamp T.L. A history and theory of informed consent oxford 1986, Oxford University Press, Oxford.
13. Fässler M., Gnädiger M., Rosemann T., Biller-Adorno N. Use of placebo interventions among Swiss primary care providers. BMC Health Serv. Res. 2009, 9:144. 10.1186/1472-6963-9-144.
14. Fässler M., Meissner K., Schnieder A., Linde K. Frequency and circumstances of placebo use in clinical practice - a systematic review of empirical studies. BMC Med. 2010, 8:15.
15. Fent R., Rosman T., Fässler M., Senn O., Huber C.A. The use of pure and impure placebo interventions in primary care - a qualitative approach. BMC Fam. Pract. 2011, 24(12):11.
16. Finniss D.G., Kaptchuck T.J., Miller F., Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010, 375:686-695.
17. Fournier J.C., DeRubeis R.J., Hollon S.D., Dimidjian S., Amsterdam J.D., Shelton R.C., Fawcett J. Antidepressant drug effects and depression severity: a patient level meta-analysis. J. Am. Med. Assoc. 2010, 303(1):47-53.
18. Goodwin J.S., Goodwin J.M., Vogel A.V. Knowledge and use of placebos by house officers and nurses. Ann. Intern. Med. 1979, 91(1):106-110.
19. Gotch F., Gilmour J. Science, medicine and research in the developing world: a perspective. Nat. Immunol. 2007, 8(12):1273-1276.
20. van der Graaf R., van Delden J.J.M. What is the best standard for the standard of care in clinical research?. Am. J. Bioethics 2009, 9(3):35-43.
21. van der Graaf, R., 2010. Ethical Fundamentals in Human Subjects Research. On Equipoise and Human Dignity. Ph.D. Thesis. Utrecht.
22. Hrobjartsson A., Goetzsche P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. N. Engl. J. Med. 2001, 344(21):1594-1602.
23. Hrobjartsson A., Goetzsche P.C. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J. Intern. Med. 2004, 256:91-100.
24. Kaptchuk T.J. Powerful placebo: the dark side of the randomized controlled trial. Lancet 1998, 351:1722-1725.
25. Kaptchuk T.J., et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS ONE 2010, 5:1-7. (December 2010, Issue 12, e15591).
26. Lemmens T., Miller P.B. Avoiding a Jekyll-and-Hyde approach to the ethics of clinical research and practice. Am. J. Bioethics 2002, 2(2):14-17.
27. Lo B. Ethical issues in clinical research. A practical guide 2010, Lippincott Williams and Wilkins, Philadelphia.
28. Macedo A., Farré M., Banos J.E. Placebo effect and placebos: what are we talking about? Some conceptual and historical considerations. Eur. J. Clin. Pharmacol. 2003, 59:337-342.
29. Meissner K., Höfner L., Fässler M., Linde K. Widespread use of pure and impure placebo interventions by GPs in Germany. Fam. Pract. 2012, 29:79-85.
30. Miller F.G., Brody H. What makes placebo-controlled trials unethical?. Am. J. Bioethics 2002, 2(2):3-9.
31. Miller F.G., Brody H. Clinical equipoise and the incoherence of research ethics. J. Med. Philos. 2007, 32:151-165.
32. Miller F.G., Colloca L. The placebo phenomenon and medical ethics: rethinking the relationship between informed consent and risk-benefit assessment. Theor. Med. Bioethics 2011, 32:229-243.
33. Miller F.G., Colloca L. The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am. J. Bioethics 2009, 9(1):39-47.
34. O'Neil O. A question of trust 2002, Cambridge University Press, Cambridge.
35. Price D.D., Finniss D.G., Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Ann. Rev. Psychol 2008, 59:565-590.
36. Schipper I., Weyzig F. Ethics for Drug Testing in Low and Middle Income Countries. Considerations for European Market Authorisation 2008, SoMo, Amsterdam.
37. Spiro M. Doctors, patients and placebos 1986, Yale University Press, New Haven/London.
38. Tilburt J.C., Emanuel E.J., Kaptchuk T.J., Curlin F.A., Miller F.G. Prescribing "placebo treatments": results of national survey of US internists and rheumatologists. Br. Med. J. 2008, 337:a1938. 10.1136/bmj.a1938.
39. Vickers A.J., De Craen A.J. Why use placebos in clinical trials? A narrative review of the methodological literature. J. Clin. Epidemiol 2000, 53:157-161.